Therefore, our findings suggested that c-Myc-miR-202-5p-PTEN axis plays an important role in promoting tumorigenesis and exhibited miR-202-5p is a valuable target in CRC therapy. The gene discussed is PTEN; the disease is colorectal carcinoma.